1. EVESOR, a model-based, multiparameter, Phase I trial to optimize the benefit/toxicity ratio of everolimus and sorafenib. (April 2017) Authors: El-Madani, Mévidette; Colomban, Olivier; Tod, Michel; Maillet, Denis; Peron, Julien; Rodriguez-Lafrasse, Claire; Badary, Osama A; Valette, Pierre-Jean; Lefort, Thibaud; Cassier, Philippe; El-Shenawy, Siham M; EL-Demerdash, Ebtehal; Hommel-Fontaine, Juliette; Guitton, Jerome; Gagnieu, Marie-Claude... Journal: Future oncology Issue: Volume 13:Number 8(2017) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗